BridgeMD
FAPI-PET for GPSD
EU CTIS ID: 2024-511977-31-01
What this study is testing
To assess the diagnostic accuracy of 68Ga-FAPI-46 PET/CT in patients with suspected GPSD.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients with suspected GPSD. In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Age ≥ 50 years - Patients must be able to adhere to the study appointments and other protocol requirements. - Patients must be capable of giving informed consent
You likely can't join if
- Patients with suspected GPSD. A potential subject who meets any of the following criteria will be excluded from participation in this study: - Suspected GPSD, - Presence of symptoms, imaging test result or biopsy findings suggesting cranial artery involvement in GPSD (‘cranial giant cell arteritis’) - Use of oral glucocorticoid treatment or disease modifying anti-rheumatic drugs at time of inclusion - Females with child bearing potential. Post-menopausal women with >12 months of amenorrhoea are considered to have no child bearing potential. Given the age distribution of patients with GPSD, exclusion of females with child bearing potential will not lead to recruitment bias in the study. - Research-related radiation exposure (cumulative ≥5 mSv) in the year before inclusion.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.